SCHEMBL10310896

SCHEMBL10310896

Cc1cccc(Nc2ccccc2C(=O)NCCOCCO)c1C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MT-CO2 P00403 3/20 0.58
▸ PTGS1 P23219 3/20 0.56
▸ PTGS2 P35354 5/20 0.54
▸ MEN1 O00255 2/20 0.54
▸ KMT2A Q03164 2/20 0.54
▸ AKR1B10 O60218 1/20 0.54
▸ TRPA1 O75762 1/20 0.54
▸ ABCB11 O95342 1/20 0.54
▸ DHFR P00374 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ MPO P05164 1/20 0.54
▸ CYP1A2 P05177 1/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ CHRM1 P11229 1/20 0.54
▸ CYP2C9 P11712 1/20 0.54
▸ AKR1B1 P15121 1/20 0.54
▸ AKR1C3 P42330 1/20 0.54
▸ AKR1C2 P52895 1/20 0.54
▸ AKR1C1 Q04828 1/20 0.54
▸ HIF1A Q16665 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13299189 0.89 SMN1; SMN2 (0.51) MT-CO2PTGS2MEN1KMT2ALMNA
SCHEMBL10310894 0.88 MT-CO2 (0.60) MT-CO2PTGS1PTGS2MEN1KMT2A
SCHEMBL13162943 0.83 NPC1 (0.59) MEN1KMT2AMAPK1
SCHEMBL13318490 0.81 PTGS2 (0.44) MT-CO2PTGS1PTGS2MEN1KMT2A
SCHEMBL18235578 0.79 SMN1; SMN2 (0.59) MEN1KMT2ALMNAMAPK1
SCHEMBL12608894 0.78 MT-CO2 (0.60) MT-CO2PTGS1PTGS2MEN1KMT2A
SCHEMBL3805715 0.77 MT-CO2 (0.59) MT-CO2PTGS1PTGS2MEN1KMT2A
SCHEMBL9262003 0.76 PTGS2 (0.69) MT-CO2PTGS1PTGS2MEN1KMT2A
SCHEMBL13013590 0.76 MT-CO2 (0.58) MT-CO2PTGS1PTGS2MEN1KMT2A
SCHEMBL9736935 0.75 PTGS2 (0.71) MT-CO2PTGS1PTGS2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9403756-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2016-08-02 — — US disclosed
US-9403756-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2016-08-02 — — US disclosed
US-20140316008-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-10-23 — — US disclosed
US-20140316008-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-10-23 — — US disclosed
US-8765815-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-07-01 — — US disclosed
US-8765815-B2 N-phenyl anthranilic acid derivatives and uses thereof RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2014-07-01 — — US disclosed
US-8278357-B2 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2012-10-02 — — US disclosed
US-8278357-B2 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2012-10-02 — — US disclosed
US-20120178785-A1 DERIVATIVES OF N-PHENYLANTHRANILIC ACID AND 2-BENZIMIDAZOLONE AS POTASSIUM CHANNEL AND/OR NEURON ACTIVITY MODULATORS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2012-07-12 — — US disclosed
US-20120178785-A1 DERIVATIVES OF N-PHENYLANTHRANILIC ACID AND 2-BENZIMIDAZOLONE AS POTASSIUM CHANNEL AND/OR NEURON ACTIVITY MODULATORS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2012-07-12 — — US disclosed
US-20100137296-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2010-06-03 — — US disclosed
US-20100137296-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2010-06-03 — — US disclosed
US-20100056591-A1 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2010-03-04 — — US disclosed
US-20100056591-A1 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) 2010-03-04 — — US disclosed
US-7632866-B2 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators RAMOT AT TEL AVIV UNIVERSITY (IL) 2009-12-15 — — US disclosed
US-7632866-B2 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators RAMOT AT TEL AVIV UNIVERSITY (IL) 2009-12-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137296-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF TRPV1, TRPA1, TRPV4 MT-CO2 2891/4885PTGS1 850/4885PTGS2 1097/4885
US-20140316008-A1 N-PHENYL ANTHRANILIC ACID DERIVATIVES AND USES THEREOF TRPV1, TRPA1, TRPV4 MT-CO2 2891/4885PTGS1 850/4885PTGS2 1097/4885
US-20120178785-A1 DERIVATIVES OF N-PHENYLANTHRANILIC ACID AND 2-BENZIMIDAZOLONE AS POTASSIUM CHANNEL AND/OR NEURON ACTIVITY MODULATORS KCNN2, KCNN1, KCNN3 MT-CO2 2706/4885PTGS1 1182/4885PTGS2 1207/4885
US-20100056591-A1 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators KCNN2, KCNN1, KCNN3 MT-CO2 2706/4885PTGS1 1182/4885PTGS2 1207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback